Jazz Pharmaceuticals plc: president & CEO Gala Renee D sold 2,000 shares

What happened Gala Renee D, president & CEO and director, sold 2,000 shares at $236.40 per share on Oct 6, 2026, for total proceeds of $472,800, according to the Form 4 filed with the SEC.

Key details

• Transaction date and price: Oct 6, 2026 — sale of 2,000 shares at $236.40 per share, total $472,800.
• Transaction code: S (sale).
• Shares owned after the transaction: the filing does not report shares owned following the transaction.
• Footnote F1: the filing says the transaction was made pursuant to a plan adopted Jun 4, 2026 under Rule 10b5-1; the transaction occurred automatically and was not a discretionary transaction by the reporting person.
• Form filed with the SEC on Oct 7, 2026; the filing does not indicate it was late.

Why it may matter

• The filing describes a market sale (code S) executed under a pre-established 10b5-1 plan.
• A filing does not show why the insider traded or why the company acted.